FRI057 Drug Concentrations And Dosing Considerations For Mibavademab, A Novel Leptin Receptor Agonist, In Individuals With Generalized Lipodystrophy

por Mendell, Jeanne, Wang, Yuhuan, Olenchock, Ben A, Podgrabinska, Simona, Pagovich, Odelya E, Oral, Elif A, Brown, Rebecca J, Davis, John
Publicado 2023

FRI059 Long-term Follow-up On Partial Lipodystrophy Treated With Leptin Receptor Agonist Mibavademab(REGN4461)

por Foss de Freitas, Maria Cristina, DillGomes, Anabela, Neidert, Adam, Podgrabinska, Simona, Olenchock, Ben, SinhaRoy, Rababir, Harris, Charles Andrew, Akinci, Baris, Altarejos, Judith, Oral, Elif A
Publicado 2023

FRI069 Treatment With Mibavademab, A Novel Leptin Receptor Agonist, Is Associated With Improvement In Weight And Associated Comorbidities In Congenital Leptin Deficiency

por Ozsu, Elif, Akin, Leyla, Aydin, Murat, Berberoglu, Merih, Stein, David, Pagovich, Odelya, Olenchock, Ben, Podgrabinska, Simona, Harris, Charles Andrew, Mendell, Jeanne, SinhaRoy, Ranabir, Altarejos, Judith, Akinci, Baris, Oral, Elif A
Publicado 2023

FRI058 Treatment With Mibavademab, A Novel Leptin Receptor Agonist, Is Associated With Improvement In Metabolic Parameters In Individuals With Generalized Lipodystrophy

por Olenchock, Ben, Podgrabinska, Simona, Hou, Christine, Musser, Bret, Mendell, Jeanne, Harman, Amy, Sanchez, Robert J, Miller, Kathryn, Parasoglou, Prodromos, Hectors, Stefanie, Karnik, Satyajit, Pagovich, Odelya E, SinhaRoy, Ranabir, Harris, Charles A, Akinci, Baris, Simsir, Ilgin Yildirim, Ozen, Samim, Sorkina, Ekaterina, Garg, Abhimanyu, Vargas Gonzalez, Rolando Jesus, Weinreich, David M, Herman, Gary, Oral, Elif A, Brown, Rebecca J
Publicado 2023